Sanjay K Agarwal, MD
Critical Care (Intensivists) · Fremont
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 29
- 7 carriers
- Office
- 1
On the public record
- 1 Medical Board action on record
Offices
1 location
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
29 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Agarwal’s office at (408) 418-0300 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
29 of 29 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A104257 · Current
Licensed to practise in California · since 2008 · expires 2027-10-31 · Bangalore University, Bangalore Medical College. Board flags: Court Order, Limitations on Practice.
Public record actions
| 2026-06-09 | Court orderDiscipline | Superior court of california, county of santa clara issued an order in case NO. C2519361, the people of the state of california vs. sanjay kumar agarwal, M.D. dr. agarwal shall cease and desist from treating female patients in the practice of medicine. |
State licence records
1 licence
- Washington MD.MD.00047235Physician And Surgeon License · since 2006 · expires 2025-10-21ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$150,112
Medicare paid this office $150,112 for 320 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 217 | $60,887 | $120 |
| Sleep study in sleep lab (6 years or older) | 38 | $26,949 | $657 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 20 | $15,366 | $698 |
| New patient visit (45+ min) | 102 | $14,938 | $146 |
| Critical care, first 30-74 minutes | 21 | $4,603 | $184 |
See all 13 services
| Return visit (30+ min) | 217 | $60,887 | $120 |
| Sleep study in sleep lab (6 years or older) | 38 | $26,949 | $657 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 20 | $15,366 | $698 |
| New patient visit (45+ min) | 102 | $14,938 | $146 |
| Critical care, first 30-74 minutes | 21 | $4,603 | $184 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,002 | $154 |
| Test to determine lung volumes using sensors | 57 | $3,769 | $60 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 77 | $3,550 | $40 |
| Test to examine how well the lungs exchange gases | 47 | $3,256 | $61 |
| Long return visit (40+ min) | 14 | $2,835 | $157 |
| Sleep study including heart rate, breathing, and sleep time | 14 | $2,593 | $144 |
| Sleep study including heart rate, breathing, airflow, and effort | 20 | $2,082 | $95 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 16 | $1,526 | $95 |
Who their Medicare patients are
320 Original Medicare patients in 2024. Average age 74 · Under 65 11% · 85 and older 14% · Women 45% · Also on Medicaid 57% · Health risk score 1.93. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 2.58.
Conditions among them: High blood pressure 75% · Diabetes 58% · Chronic kidney disease 41% · Coronary heart disease 39% · COPD 35% · Heart failure 32% · Atrial fibrillation 23% · Depression 23% · Dementia 14% · Cancer 13% · Stroke 10%.
The office billed $360,037, Medicare allowed $193,145 and paid $150,112; for 1,076 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 320 | 1,076 | 74 | 1.93 | $360,037 | $150,112 |
| 2023 | 333 | 1,128 | 73 | 1.75 | $366,548 | $158,505 |
| 2022 | 256 | 803 | 74 | 1.73 | $235,146 | $105,423 |
| 2021 | 236 | 879 | 74 | 1.70 | $248,978 | $124,803 |
| 2020 | 217 | 844 | 75 | 1.98 | $213,115 | $106,320 |
| 2019 | 281 | 1,498 | 75 | 2.25 | $368,530 | $182,929 |
| 2018 | 267 | 1,023 | 72 | 2.10 | $292,160 | $137,685 |
| 2017 | 232 | 1,411 | 75 | 2.29 | $362,895 | $176,814 |
| 2016 | 266 | 1,448 | 74 | 2.57 | $397,640 | $168,045 |
| 2015 | 249 | 1,557 | 74 | 2.40 | $438,185 | $193,006 |
| 2014 | 298 | 1,723 | 75 | 2.29 | $538,765 | $224,113 |
| 2013 | 315 | 1,459 | 74 | 2.57 | $430,447 | $194,380 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Return visit (30+ min) | 247 | $63,670 | $118 |
| Sleep study in sleep lab (6 years or older) | 51 | $35,018 | $648 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 25 | $19,787 | $682 |
| New patient visit (45+ min) | 97 | $13,794 | $142 |
| Sleep study including heart rate, breathing, airflow, and effort | 42 | $4,776 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,379 | $156 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 80 | $3,290 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,246 | $107 |
| Long return visit (40+ min) | 11 | $2,163 | $155 |
| Test to examine how well the lungs exchange gases | 34 | $1,846 | $54 |
| Test to determine lung volumes using sensors | 33 | $1,703 | $52 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 16 | $1,533 | $90 |
| Test to determine lung volumes using sensors | 19 | $203 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 19 | $174 | $9 |
| Test to examine how well the lungs exchange gases | 19 | $150 | $8 |
2022: 9 services
| Return visit (30+ min) | 192 | $48,722 | $117 |
| Sleep study in sleep lab (6 years or older) | 33 | $22,104 | $650 |
| New patient visit (45+ min) | 107 | $14,836 | $139 |
| Sleep study including heart rate, breathing, airflow, and effort | 25 | $2,583 | $86 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 33 | $1,363 | $41 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 15 | $997 | $66 |
| Test to determine lung volumes using sensors | 24 | $274 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 24 | $234 | $9 |
| Test to examine how well the lungs exchange gases | 24 | $203 | $8 |
2021: 11 services
| Return visit (30+ min) | 195 | $52,028 | $125 |
| Sleep study in sleep lab (6 years or older) | 34 | $22,768 | $670 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 21 | $14,010 | $667 |
| New patient visit (45+ min) | 82 | $12,056 | $147 |
| Test to examine how well the lungs exchange gases | 70 | $4,717 | $65 |
| Test to determine lung volumes using sensors | 70 | $4,262 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,706 | $185 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 71 | $3,674 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,816 | $96 |
| Sleep study including heart rate, breathing, airflow, and effort | 14 | $1,566 | $104 |
| Short return visit (20+ min) | 13 | $1,083 | $77 |
2020: 11 services
| Return visit (30+ min) | 182 | $40,942 | $102 |
| Sleep study in sleep lab (6 years or older) | 31 | $20,782 | $649 |
| New patient visit (45+ min) | 67 | $9,818 | $147 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 11 | $8,644 | $665 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 64 | $4,211 | $64 |
| Test to examine how well the lungs exchange gases | 64 | $4,062 | $62 |
| Test to determine lung volumes using sensors | 64 | $3,812 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $3,616 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $3,435 | $181 |
| Sleep study including heart rate, breathing, airflow, and effort | 18 | $2,551 | $121 |
| Short return visit (20+ min) | 21 | $1,859 | $69 |
2019: 12 services
| Return visit (30+ min) | 193 | $47,877 | $101 |
| Sleep study in sleep lab (6 years or older) | 44 | $27,524 | $626 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $22,750 | $94 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 32 | $21,538 | $653 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $16,646 | $183 |
| New patient visit (45+ min) | 89 | $13,348 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 59 | $10,855 | $66 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 86 | $5,278 | $61 |
| Test to determine lung volumes using sensors | 85 | $4,780 | $56 |
| Test to examine how well the lungs exchange gases | 80 | $4,697 | $58 |
| Short return visit (20+ min) | 20 | $1,642 | $71 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 14 | $1,240 | $89 |
2018: 12 services
| Return visit (30+ min) | 157 | $38,559 | $97 |
| Sleep study in sleep lab (6 years or older) | 40 | $25,995 | $650 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 30 | $21,393 | $648 |
| New patient visit (45+ min) | 90 | $12,886 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $9,549 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $8,166 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $4,380 | $65 |
| Short return visit (20+ min) | 43 | $2,708 | $60 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 44 | $2,609 | $58 |
| Test to determine lung volumes using sensors | 44 | $2,360 | $52 |
| Test to examine how well the lungs exchange gases | 36 | $1,976 | $53 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 14 | $1,473 | $105 |
2017: 12 services
| Return visit (30+ min) | 144 | $38,204 | $99 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 33 | $24,380 | $677 |
| Sleep study in sleep lab (6 years or older) | 32 | $21,709 | $638 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $18,042 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 73 | $16,584 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $16,497 | $181 |
| New patient visit (45+ min) | 55 | $7,407 | $135 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 52 | $3,279 | $61 |
| Test to determine lung volumes using sensors | 50 | $2,719 | $52 |
| Test to examine how well the lungs exchange gases | 41 | $2,407 | $56 |
| Short return visit (20+ min) | 16 | $1,453 | $69 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 17 | $911 | $54 |
2016: 15 services
| Critical care, first 30-74 minutes | 29 | $29,825 | $195 |
| Return visit (30+ min) | 118 | $28,190 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 113 | $21,246 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 82 | $16,687 | $92 |
| Sleep study in sleep lab (6 years or older) | 22 | $14,781 | $643 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 19 | $12,508 | $658 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $11,598 | $173 |
| New patient visit (45+ min) | 54 | $7,365 | $136 |
| Critical care, each additional 30 minutes | 20 | $7,362 | $98 |
| Sleep study including heart rate, breathing, airflow, and effort | 21 | $3,717 | $169 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 42 | $2,750 | $62 |
| Test to examine how well the lungs exchange gases | 42 | $2,478 | $56 |
| Test to determine lung volumes using sensors | 42 | $2,372 | $54 |
| Short return visit (20+ min) | 29 | $2,196 | $69 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 13 | $1,550 | $103 |
2015: 17 services
| Critical care, first 30-74 minutes | 35 | $31,380 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $30,785 | $93 |
| Return visit (30+ min) | 115 | $27,655 | $99 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 30 | $20,835 | $672 |
| Sleep study in sleep lab (6 years or older) | 29 | $19,800 | $639 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $14,033 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $12,375 | $179 |
| Critical care, each additional 30 minutes | 26 | $12,073 | $98 |
| New patient visit (45+ min) | 43 | $6,177 | $144 |
| Long return visit (40+ min) | 16 | $2,711 | $129 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 36 | $2,107 | $59 |
| Test to examine how well the lungs exchange gases | 37 | $2,083 | $56 |
| Test to determine lung volumes using sensors | 37 | $1,917 | $52 |
| Short return visit (20+ min) | 11 | $687 | $62 |
| Test to determine lung volumes using sensors | 14 | $166 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 13 | $165 | $12 |
| Test to examine how well the lungs exchange gases | 14 | $123 | $8 |
2014: 21 services
| Critical care, first 30-74 minutes | 49 | $34,359 | $194 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 47 | $32,418 | $648 |
| Sleep study in sleep lab (6 years or older) | 43 | $27,494 | $625 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 104 | $25,177 | $90 |
| Return visit (30+ min) | 106 | $22,308 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 103 | $18,859 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 101 | $15,900 | $62 |
| Critical care, each additional 30 minutes | 35 | $12,518 | $98 |
| New patient visit (45+ min) | 40 | $5,611 | $140 |
| Short return visit (20+ min) | 40 | $4,019 | $66 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 57 | $3,472 | $60 |
| Test to examine how well the lungs exchange gases | 54 | $3,047 | $55 |
| Test to determine lung volumes using sensors | 52 | $2,784 | $53 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 20 | $2,668 | $107 |
| Long return visit (40+ min) | 15 | $2,339 | $130 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 16 | $2,206 | $116 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,704 | $122 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 12 | $1,242 | $96 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 15 | $176 | $12 |
| Test to determine lung volumes using sensors | 14 | $155 | $11 |
| Test to examine how well the lungs exchange gases | 14 | $114 | $8 |
2013: 14 services
| Critical care, first 30-74 minutes | 63 | $35,846 | $190 |
| Sleep study in sleep lab (6 years or older) | 54 | $34,909 | $646 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 38 | $26,585 | $682 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 133 | $21,368 | $61 |
| Return visit (30+ min) | 81 | $14,312 | $97 |
| Critical care, each additional 30 minutes | 35 | $11,784 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $11,631 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $11,032 | $172 |
| Short return visit (20+ min) | 71 | $8,792 | $63 |
| New patient visit (45+ min) | 40 | $5,954 | $149 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 14 | $1,070 | $76 |
| Test to determine lung volumes using sensors | 16 | $174 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 15 | $173 | $12 |
| Test to examine how well the lungs exchange gases | 16 | $127 | $8 |
Medicaid work
$9,660 in 2024
Medicaid paid $9,660 for 713 billed services this clinician did in 2024, up to 50 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 637 | $8,570 |
| New patient visit (45+ min) | 63 | $983 |
| EVALUATION OF WHEEZING | 13 | $107 |
| 2024 | 713 | 3 | 50 | $9,660 |
| 2023 | 1,041 | 5 | 74 | $11,557 |
| 2022 | 894 | 5 | 59 | $7,364 |
| 2021 | 869 | 7 | 53 | $5,421 |
| 2020 | 672 | 7 | 58 | $926 |
| 2019 | 723 | 8 | 56 | $743 |
| 2018 | 559 | 4 | 44 | $4,548 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 695 | $7,660 |
| New patient visit (45+ min) | 168 | $3,014 |
| EVALUATION OF WHEEZING | 144 | $877 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 17 | $4 |
| Diffusing capacity | 17 | $2 |
2022
| Return visit (30+ min) | 500 | $4,229 |
| New patient visit (45+ min) | 93 | $2,679 |
| EVALUATION OF WHEEZING | 74 | $456 |
| Advance Care Planning discussed and documented in the medical record, patient did not wish or was not able to name a surrogate decision maker or provide an advance care plan (DEM) (GER, Pall Cr) | 32 | $0 |
| Patient screened for tobacco use and identified as a tobacco non-user | 195 | $0 |
2021
| Return visit (30+ min) | 526 | $3,567 |
| New patient visit (45+ min) | 71 | $1,417 |
| Diffusing capacity | 41 | $163 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 41 | $148 |
| EVALUATION OF WHEEZING | 41 | $127 |
| Patient not eligible due to active diagnosis of hypertension | 47 | $0 |
| Patient screened for tobacco use and identified as a tobacco non-user | 102 | $0 |
2020
| Return visit (30+ min) | 448 | $734 |
| New patient visit (45+ min) | 48 | $193 |
| EVALUATION OF WHEEZING | 45 | $0 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 45 | $0 |
| Diffusing capacity | 45 | $0 |
| Short return visit (20+ min) | 13 | $0 |
| Patient screened for tobacco use and identified as a tobacco non-user | 28 | $0 |
2019
| Return visit (30+ min) | 478 | $519 |
| 1ST HOSP IP/OBS HIGH 75 | 28 | $80 |
| Diffusing capacity | 15 | $72 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 16 | $70 |
| EVALUATION OF WHEEZING | 15 | $2 |
| New patient visit (45+ min) | 52 | $0 |
| Patient not eligible due to active diagnosis of hypertension | 29 | $0 |
| Patient screened for tobacco use and identified as a tobacco non-user | 90 | $0 |
2018
| Return visit (30+ min) | 435 | $2,478 |
| Short return visit (20+ min) | 30 | $1,413 |
| New patient visit (45+ min) | 38 | $657 |
| Patient screened for tobacco use and identified as a tobacco non-user | 56 | $0 |
Drugs they prescribed that Part D paid
$805,158
Pharmacies billed $805,158 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,675) in 2024. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 0%.
674 generic and 1,001 brand-name prescriptions · $805,158 in drug cost · 103 antibiotic prescriptions to 56 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofev | 32 | $412,290 | $12,884 |
| Trelegy Ellipta | 195 | $132,775 | $681 |
| Breo Ellipta | 144 | $52,896 | $367 |
| Arnuity Ellipta | 128 | $33,913 | $265 |
| Spiriva Respimat | 39 | $24,251 | $622 |
See all 30 drugs
| Ofev | 32 | $412,290 | $12,884 |
| Trelegy Ellipta | 195 | $132,775 | $681 |
| Breo Ellipta | 144 | $52,896 | $367 |
| Arnuity Ellipta | 128 | $33,913 | $265 |
| Spiriva Respimat | 39 | $24,251 | $622 |
| Advair Hfa | 45 | $17,167 | $381 |
| Fluticasone Propionate Hfa | 63 | $15,595 | $248 |
| Budesonide-Formoterol | 87 | $12,510 | $144 |
| Incruse Ellipta | 27 | $11,154 | $413 |
| Fluticasone-Salmeterol | 69 | $8,779 | $127 |
| Breyna | 72 | $8,526 | $118 |
| Symbicort | 23 | $6,772 | $294 |
| Dulera | 15 | $5,042 | $336 |
| Albuterol Sulfate Hfa | 159 | $3,868 | $24 |
| Wixela Inhub | 30 | $3,411 | $114 |
| Roflumilast | 26 | $2,216 | $85 |
| Pantoprazole | 139 | $1,179 | $8 |
| Clarithromycin | 12 | $840 | $70 |
| Ethambutol | 16 | $762 | $48 |
| Ventolin Hfa | 11 | $594 | $54 |
| Famotidine | 13 | $283 | $22 |
| Gabapentin | 30 | $211 | $7 |
| Montelukast | 22 | $187 | $8 |
| Amoxicillin-Clavulanate Potass | 19 | $183 | $10 |
| Isoniazid | 36 | $165 | $5 |
| Levofloxacin | 26 | $158 | $6 |
| Ropinirole | 11 | $142 | $13 |
| Azithromycin | 36 | $123 | $3 |
| Pramipexole Dihydrochloride | 19 | $101 | $5 |
| Prednisone | 13 | $84 | $6 |
Year by year
| 2024 | 1,675 | 315 | 0% (0) | 60% | $805,158 |
| 2023 | 1,681 | 320 | 0% (0) | 66% | $938,633 |
| 2022 | 1,757 | 306 | 0% (0) | 65% | $837,524 |
| 2021 | 2,046 | 326 | 0% (0) | 65% | $723,588 |
| 2020 | 1,992 | 267 | 0% (0) | 64% | $515,227 |
| 2019 | 1,637 | 256 | 0% (0) | 64% | $517,988 |
| 2018 | 1,177 | 204 | None | 56% | $307,755 |
| 2017 | 1,139 | 161 | None | 52% | $241,653 |
| 2016 | 669 | 145 | 4% (25) | 43% | $133,322 |
| 2015 | 534 | 123 | 2% (12) | 51% | $131,605 |
| 2014 | 344 | 93 | None | 47% | $53,320 |
| 2013 | 281 | 80 | None | 22% | $15,392 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 31 drugs
| Ofev | 24 | $341,069 | $14,211 |
| Trelegy Ellipta | 204 | $165,205 | $810 |
| Breo Ellipta | 173 | $80,286 | $464 |
| Symbicort | 129 | $56,888 | $441 |
| Advair Hfa | 72 | $39,364 | $547 |
| Flovent Hfa | 86 | $30,218 | $351 |
| Arnuity Ellipta | 109 | $29,808 | $273 |
| Spiriva Respimat | 37 | $27,232 | $736 |
| Advair Diskus | 35 | $20,335 | $581 |
| Spiriva Handihaler | 13 | $17,075 | $1,313 |
| Incruse Ellipta | 39 | $16,027 | $411 |
| Wixela Inhub | 40 | $13,083 | $327 |
| Daliresp | 12 | $6,269 | $522 |
| Roflumilast | 22 | $4,916 | $223 |
| Fluticasone-Vilanterol | 12 | $3,999 | $333 |
| Fluticasone Propionate Hfa | 17 | $3,857 | $227 |
| Budesonide-Formoterol | 15 | $3,782 | $252 |
| Albuterol Sulfate Hfa | 86 | $2,938 | $34 |
| Qvar Redihaler | 11 | $2,821 | $256 |
| Ventolin Hfa | 21 | $2,217 | $106 |
| Fluticasone-Salmeterol | 12 | $1,826 | $152 |
| Pantoprazole | 147 | $1,578 | $11 |
| Rifampin | 15 | $1,046 | $70 |
| Montelukast | 52 | $716 | $14 |
| Pramipexole Dihydrochloride | 30 | $445 | $15 |
| Azithromycin | 33 | $434 | $13 |
| Prednisone | 17 | $238 | $14 |
| Amoxicillin-Clavulanate Potass | 12 | $176 | $15 |
| Levofloxacin | 20 | $144 | $7 |
| Gabapentin | 26 | $109 | $4 |
| Citalopram Hbr | 19 | $54 | $3 |
2022: 27 drugs
| Ofev | 21 | $256,052 | $12,193 |
| Trelegy Ellipta | 204 | $144,188 | $707 |
| Breo Ellipta | 281 | $121,973 | $434 |
| Spiriva Respimat | 84 | $52,987 | $631 |
| Symbicort | 92 | $43,503 | $473 |
| Advair Hfa | 47 | $32,481 | $691 |
| Daliresp | 45 | $28,366 | $630 |
| Spiriva Handihaler | 44 | $27,436 | $624 |
| Arnuity Ellipta | 87 | $24,761 | $285 |
| Flovent Hfa | 39 | $12,644 | $324 |
| Wixela Inhub | 50 | $11,301 | $226 |
| Albuterol Sulfate Hfa | 128 | $6,898 | $54 |
| Incruse Ellipta | 17 | $6,409 | $377 |
| Advair Diskus | 11 | $5,860 | $533 |
| Flovent Diskus | 17 | $4,820 | $284 |
| Rifampin | 41 | $2,799 | $68 |
| Clarithromycin | 37 | $2,398 | $65 |
| Ethambutol | 41 | $1,730 | $42 |
| Pantoprazole | 167 | $1,502 | $9 |
| Moxifloxacin | 12 | $1,077 | $90 |
| Azithromycin | 25 | $788 | $32 |
| Montelukast | 38 | $658 | $17 |
| Pramipexole Dihydrochloride | 52 | $479 | $9 |
| Amoxicillin-Clavulanate Potass | 12 | $288 | $24 |
| Famotidine | 11 | $200 | $18 |
| Levofloxacin | 25 | $120 | $5 |
| Citalopram Hbr | 15 | $79 | $5 |
2021: 33 drugs
| Breo Ellipta | 360 | $144,668 | $402 |
| Ofev | 13 | $141,758 | $10,904 |
| Trelegy Ellipta | 116 | $71,694 | $618 |
| Spiriva | 94 | $55,393 | $589 |
| Spiriva Respimat | 104 | $53,485 | $514 |
| Symbicort | 58 | $33,123 | $571 |
| Advair Hfa | 41 | $32,304 | $788 |
| Daliresp | 55 | $31,716 | $577 |
| Arnuity Ellipta | 118 | $27,708 | $235 |
| Incruse Ellipta | 60 | $24,260 | $404 |
| Advair Diskus | 34 | $18,694 | $550 |
| Wixela Inhub | 72 | $16,946 | $235 |
| Flovent Hfa | 32 | $10,877 | $340 |
| Anoro Ellipta | 18 | $8,268 | $459 |
| Xarelto | 14 | $7,094 | $507 |
| Albuterol Sulfate Hfa | 124 | $6,318 | $51 |
| Fluticasone-Salmeterol | 20 | $5,392 | $270 |
| Budesonide-Formoterol | 16 | $4,800 | $300 |
| Rifampin | 52 | $3,107 | $60 |
| Clarithromycin | 40 | $2,228 | $56 |
| Pantoprazole | 187 | $1,850 | $10 |
| Alvesco | 14 | $1,801 | $129 |
| Ethambutol | 38 | $1,715 | $45 |
| Ventolin Hfa | 23 | $1,657 | $72 |
| Montelukast | 65 | $777 | $12 |
| Pramipexole Dihydrochloride | 58 | $369 | $6 |
| Bupropion Xl | 21 | $326 | $16 |
| Levothyroxine | 12 | $206 | $17 |
| Amoxicillin-Clavulanate Potass | 18 | $178 | $10 |
| Isoniazid | 13 | $82 | $6 |
| Citalopram Hbr | 16 | $80 | $5 |
| Gabapentin | 11 | $60 | $5 |
| Levofloxacin | 17 | $49 | $3 |
2020: 34 drugs
| Breo Ellipta | 414 | $165,084 | $399 |
| Spiriva | 122 | $61,231 | $502 |
| Advair Diskus | 72 | $46,140 | $641 |
| Incruse Ellipta | 89 | $34,223 | $385 |
| Advair Hfa | 50 | $28,166 | $563 |
| Arnuity Ellipta | 116 | $25,393 | $219 |
| Trelegy Ellipta | 40 | $22,253 | $556 |
| Spiriva Respimat | 32 | $16,983 | $531 |
| Symbicort | 39 | $16,091 | $413 |
| Wixela Inhub | 41 | $13,260 | $323 |
| Daliresp | 27 | $12,850 | $476 |
| Fluticasone-Salmeterol | 27 | $7,694 | $285 |
| Anoro Ellipta | 17 | $7,351 | $432 |
| Flovent Hfa | 16 | $5,902 | $369 |
| Ventolin Hfa | 64 | $5,339 | $83 |
| Albuterol Sulfate Hfa | 102 | $5,324 | $52 |
| Dulera | 13 | $4,186 | $322 |
| Clarithromycin | 15 | $1,680 | $112 |
| Pantoprazole | 241 | $1,453 | $6 |
| Proair Respiclick | 12 | $1,091 | $91 |
| Ethambutol | 13 | $1,065 | $82 |
| Rifampin | 20 | $1,019 | $51 |
| Montelukast | 55 | $524 | $10 |
| Prednisone | 29 | $384 | $13 |
| Pramipexole Dihydrochloride | 65 | $362 | $6 |
| Bupropion Xl | 16 | $351 | $22 |
| Amoxicillin-Clavulanate Potass | 26 | $291 | $11 |
| Azithromycin | 12 | $262 | $22 |
| Levothyroxine | 12 | $206 | $17 |
| Levofloxacin | 31 | $140 | $5 |
| Isoniazid | 18 | $131 | $7 |
| Furosemide | 13 | $78 | $6 |
| Citalopram Hbr | 21 | $77 | $4 |
| Famotidine | 12 | $53 | $4 |
2019: 28 drugs
| Breo Ellipta | 294 | $107,900 | $367 |
| Spiriva | 100 | $43,771 | $438 |
| Advair Diskus | 60 | $34,039 | $567 |
| Incruse Ellipta | 94 | $33,979 | $361 |
| Advair Hfa | 57 | $26,209 | $460 |
| Symbicort | 68 | $25,690 | $378 |
| Arnuity Ellipta | 86 | $19,751 | $230 |
| Spiriva Respimat | 30 | $15,844 | $528 |
| Trelegy Ellipta | 28 | $15,229 | $544 |
| Rifabutin | 12 | $14,176 | $1,181 |
| Anoro Ellipta | 26 | $10,599 | $408 |
| Flovent Hfa | 22 | $10,306 | $468 |
| Daliresp | 14 | $7,717 | $551 |
| Dulera | 20 | $6,101 | $305 |
| Qvar Redihaler | 24 | $5,420 | $226 |
| Wixela Inhub | 20 | $4,488 | $224 |
| Clarithromycin | 15 | $2,638 | $176 |
| Ventolin Hfa | 34 | $2,196 | $65 |
| Pantoprazole | 224 | $1,602 | $7 |
| Albuterol Sulfate Hfa | 15 | $639 | $43 |
| Pramipexole Dihydrochloride | 70 | $560 | $8 |
| Montelukast | 27 | $402 | $15 |
| Amoxicillin-Clavulanate Potass | 25 | $334 | $13 |
| Levofloxacin | 25 | $153 | $6 |
| Citalopram Hbr | 17 | $120 | $7 |
| Famotidine | 17 | $96 | $6 |
| Prednisone | 11 | $79 | $7 |
| Furosemide | 14 | $41 | $3 |
2018: 20 drugs
| Breo Ellipta | 194 | $69,777 | $360 |
| Spiriva | 58 | $26,690 | $460 |
| Symbicort | 60 | $23,007 | $383 |
| Advair Diskus | 34 | $17,585 | $517 |
| Anoro Ellipta | 36 | $14,416 | $400 |
| Incruse Ellipta | 41 | $13,851 | $338 |
| Spiriva Respimat | 31 | $13,143 | $424 |
| Advair Hfa | 26 | $11,173 | $430 |
| Arnuity Ellipta | 53 | $11,145 | $210 |
| Budesonide | 11 | $5,534 | $503 |
| Qvar Redihaler | 14 | $2,991 | $214 |
| Ventolin Hfa | 31 | $1,922 | $62 |
| Pantoprazole | 153 | $1,263 | $8 |
| Proair Hfa | 15 | $1,112 | $74 |
| Pramipexole Dihydrochloride | 79 | $601 | $8 |
| Amoxicillin-Clavulanate Potass | 23 | $593 | $26 |
| Montelukast | 20 | $168 | $8 |
| Levothyroxine | 14 | $142 | $10 |
| Levofloxacin | 19 | $119 | $6 |
| Gabapentin | 13 | $90 | $7 |
2017: 33 drugs
| Spiriva | 83 | $39,599 | $477 |
| Advair Diskus | 60 | $28,232 | $471 |
| Breo Ellipta | 72 | $24,990 | $347 |
| Symbicort | 78 | $22,599 | $290 |
| Incruse Ellipta | 23 | $7,594 | $330 |
| Advair Hfa | 13 | $4,865 | $374 |
| Spiriva Respimat | 13 | $4,782 | $368 |
| Dulera | 15 | $4,658 | $311 |
| Flovent Hfa | 17 | $4,355 | $256 |
| Qvar | 18 | $4,056 | $225 |
| Pulmicort Flexhaler | 14 | $2,488 | $178 |
| Eliquis | 20 | $2,121 | $106 |
| Ventolin Hfa | 29 | $2,024 | $70 |
| Proair Hfa | 15 | $1,071 | $71 |
| Pantoprazole | 94 | $794 | $8 |
| Amoxicillin-Clavulanate Potass | 16 | $387 | $24 |
| Atorvastatin | 26 | $377 | $14 |
| Omeprazole | 26 | $244 | $9 |
| Donepezil | 25 | $221 | $9 |
| Risperidone | 15 | $207 | $14 |
| Pramipexole Dihydrochloride | 27 | $206 | $8 |
| Sertraline | 29 | $196 | $7 |
| Furosemide | 33 | $184 | $6 |
| Potassium Chloride | 16 | $171 | $11 |
| Montelukast | 16 | $124 | $8 |
| Finasteride | 11 | $116 | $11 |
| Clopidogrel | 11 | $109 | $10 |
| Levothyroxine | 11 | $100 | $9 |
| Gabapentin | 14 | $95 | $7 |
| Lisinopril | 14 | $88 | $6 |
| Atenolol | 15 | $74 | $5 |
| Levofloxacin | 17 | $69 | $4 |
| Amlodipine Besylate | 11 | $43 | $4 |
2016: 18 drugs
| Spiriva | 45 | $16,228 | $361 |
| Dulera | 51 | $13,079 | $256 |
| Symbicort | 44 | $12,533 | $285 |
| Advair Diskus | 18 | $7,356 | $409 |
| Dexilant | 11 | $3,668 | $333 |
| Qvar | 16 | $3,235 | $202 |
| Clarithromycin | 14 | $2,057 | $147 |
| Ventolin Hfa | 19 | $1,485 | $78 |
| Ethambutol | 15 | $1,149 | $77 |
| Proair Hfa | 15 | $1,140 | $76 |
| Amoxicillin-Clavulanate Potass | 15 | $610 | $41 |
| Tamsulosin | 12 | $376 | $31 |
| Pantoprazole | 38 | $348 | $9 |
| Pramipexole Dihydrochloride | 45 | $309 | $7 |
| Atorvastatin | 13 | $146 | $11 |
| Doxepin | 11 | $124 | $11 |
| Omeprazole | 12 | $119 | $10 |
| Gabapentin | 12 | $94 | $8 |
2015: 14 drugs
| Rifabutin | 14 | $15,465 | $1,105 |
| Advair Diskus | 41 | $14,328 | $349 |
| Spiriva | 44 | $14,085 | $320 |
| Dulera | 46 | $10,773 | $234 |
| Symbicort | 33 | $8,763 | $266 |
| Qvar | 13 | $2,384 | $183 |
| Proair Hfa | 23 | $2,130 | $93 |
| Ethambutol | 14 | $1,343 | $96 |
| Pantoprazole | 47 | $553 | $12 |
| Pramipexole Dihydrochloride | 37 | $531 | $14 |
| Amoxicillin-Clavulanate Potass | 17 | $447 | $26 |
| Azithromycin | 13 | $234 | $18 |
| Omeprazole | 12 | $102 | $8 |
| Isoniazid | 15 | $101 | $7 |
2014: 7 drugs
| Advair Diskus | 30 | $10,059 | $335 |
| Spiriva | 24 | $7,194 | $300 |
| Dulera | 15 | $3,209 | $214 |
| Symbicort | 12 | $2,746 | $229 |
| Proair Hfa | 31 | $2,385 | $77 |
| Pramipexole Dihydrochloride | 47 | $1,082 | $23 |
| Pantoprazole | 45 | $421 | $9 |
2013: 5 drugs
| Symbicort | 12 | $3,282 | $274 |
| Pramipexole Dihydrochloride | 54 | $1,094 | $20 |
| Proair Hfa | 14 | $828 | $59 |
| Amox Tr-Potassium Clavulanate | 14 | $386 | $28 |
| Pantoprazole | 30 | $298 | $10 |
Money from drug and device companies
$55 in 2025
| 2025 | 1 | 1 | None | $55 |
| 2024 | 5 | 5 | None | $188 |
| 2022 | 2 | 2 | None | $162 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Inspire Medical Systems | Inspire | $55 | 1 payment
|
See the published payment
| Inspire Medical Systems | Meals · 2025-01-17 | Inspire | $55 |
See earlier years (2024, 2022)
2024: $188
| Inspire Medical Systems | Inspire | $86 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $48 | 1 payment
|
| Aimmune Therapeutics | Vowst | $21 | 1 payment
|
| Philips North America | (6299) Dreamwear | $20 | 1 payment
|
| CapsoVision | Capsocam Plus | $13 | 1 payment
|
2022: $162
| Boehringer Ingelheim Pharmaceuticals | Ofev | $145 | 1 payment
|
| Resmed | Air 11 | $17 | 1 payment
|
Checkups this office reported
2023
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 65.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Offers telehealth visits
- Records advance care plans
- Tobacco use
Professional record
- NPI
- 1477523249
- Licence
- CA A104257, OR MD184939, WA MD00047235California A104257: Current · expires 2027-10-31Washington MD.MD.00047235: Expired
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RS0012X (207RS0012X); Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 201 16th Ave E, Seattle, WA, 98112
- NPI first listed
- 2006-01-25
- NPI last updated
- 2022-01-26
- NPI record certified
- 2022-01-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 888 Swift Blvd, Richland, WA, 99352
This office lists an electronic records connection.